Tenacissoside I
CAS: 191729-44-9
Ref. 3D-FT74349
| 2mg | Nachfragen | ||
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Produktinformation
- (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl benzoate
- Pregnan-20-one, 12-(acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-, (3β,5α,11α,12β,14be ta,17α)-
- (3beta,5alpha,11alpha,12beta,14beta,17alpha)-12-(Acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxypregnan-20-one
- Tenacissimoside B
Tenacissoside I is a polyhydroxylated triterpene compound derived from the Chinese herb, Tenacissus. It has been shown to have an anticancer activity by binding to epidermal growth factor receptor and blocking the downstream signaling pathway. Tenacissoside I has also been found to inhibit glucose uptake in human liver cells. This drug is then metabolized into tenacissoside II and tenacissoside III, which are also active compounds. Tenacissoside I inhibits protein synthesis by competing with insulin for its receptor on the surface of cells, which results in a decreased glucose uptake.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FT74349 Tenacissoside I
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
